SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Income Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Adjusted EPS | ₹-10.55 | ₹-11.93 | ₹-6.86 | ₹-6.86 |
What is the latest Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹-10.55 |
| Mar2025 | ₹-11.93 |
| Mar2024 | ₹-6.86 |
| Mar2023 | ₹-6.86 |
How is Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹-10.55 | Negative | |
| Mar2025 | ₹-11.93 | Negative | |
| Mar2024 | ₹-6.86 | Negative | |
| Mar2023 | ₹-6.86 | - | |
Compare Earnings Per Share (EPS) of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,788.5 Cr | 6.6% | 7.6% | 42.2% | Stock Analytics | |
| PRIME FOCUS | ₹24,488.5 Cr | -10.8% | 4.1% | 73.1% | Stock Analytics | |
| SAGILITY | ₹20,948.9 Cr | -2.6% | 1.5% | -3.3% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,266.8 Cr | -1.9% | -8% | -42.9% | Stock Analytics | |
| INDEGENE | ₹14,688.1 Cr | 2.3% | 7% | 1.2% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,259.1 Cr | 2% | -5.3% | -12.4% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 6.6% |
7.6% |
42.2% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses